AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Glimoso M 1mg/500mg Tablet

Prescription Icon
Prescription Required

Marketer

Ablus Pharma

Salt Composition

Glimepiride (1mg) + Metformin (500mg)

Overview Glimoso M 1mg/500mg Tablet

Diabex Duo 1mg/500mg tablets are classified as antidiabetic medications, combining two active components for adult type 2 diabetes management. This dual-action formulation helps regulate blood glucose. Administer Diabex Duo with food, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on your blood sugar response. Continuous use is crucial; discontinuation without medical supervision risks elevated blood sugar, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. This medication complements a holistic diabetes management plan, encompassing a balanced diet, regular exercise, and weight management as directed by your doctor. Lifestyle choices significantly impact diabetes control. Hypoglycemia (low blood sugar) is a common adverse effect. Learn to identify symptoms like sweating, dizziness, headache, and tremors, and know how to manage them using fast-acting glucose sources (e.g., sugary snacks or juice). Alcohol consumption elevates hypoglycemia risk and should be limited. Other potential side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, and upper respiratory infections. Weight gain may occur. Do not use Diabex Duo if you have type 1 diabetes, diabetic ketoacidosis, or severe liver or kidney disease. Inform your doctor of any history of heart conditions before starting treatment; it may be unsuitable. Pregnant or lactating individuals should consult their physician before use. Regular blood glucose monitoring is essential, along with potential blood tests to track blood cell counts and liver function.

Major Benefits of Glimoso M 1mg/500mg Tablet:

Administer this medication precisely as your physician directs, adhering to the prescribed dosage and treatment schedule. Ingest the Glimoso M 1mg/500mg tablet whole; avoid chewing, crushing, or breaking it. Consume with food.

Common Side effects of Glimoso M 1mg/500mg Tablet:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Glimoso M 1mg/500mg Tablet:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Glimoso M 1mg/500mg Tablet whole; do not crush, chew, or divide it. Administer this medicine with a meal.

How Glimoso M 1mg/500mg Tablet works:

Glimoso M, a 1mg/500mg tablet, unites the antidiabetic actions of glimepiride and metformin. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion to reduce blood sugar. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose uptake, and enhancing insulin responsiveness.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Consuming alcohol concurrently with Glimoso M 1mg/500mg tablets is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Glimoso M 1mg/500mg tablets during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to the fetus. A physician will assess the potential advantages against any possible dangers prior to prescribing. Seek medical advice before taking this medication.

Breast feedingBreast feedingUNSAFE

Lactation and Glimoso M 1mg/500mg tablets are incompatible. Evidence indicates potential infant harm from this medication.

DrivingDrivingCAUTION

Impaired driving is a possibility if your blood glucose level is either excessively low or elevated. Refrain from driving should these conditions arise.

KidneyKidneyCAUTION

Patients with kidney impairment should use Glimoso M 1mg/500mg tablets cautiously, potentially requiring dosage modification. Consult your physician. For patients with severe kidney disease, this medication is contraindicated. Regular monitoring of kidney function is recommended during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Glimoso M 1mg/500mg tablets cautiously, potentially requiring dosage modification. Medical advice is essential. For those with mild to moderate liver disease, a low initial dose is typical; however, the medication is contraindicated in cases of severe liver dysfunction.

What if you forget to take Glimoso M 1mg/500mg Tablet :

NA

Facts to Know About Glimoso M 1mg/500mg Tablet

LabelValue
Addictive None.
Medication Classification Medication for diabetes

FAQs on Glimoso M 1mg/500mg Tablet

Store this medication in its original, tightly sealed container. Follow the storage guidelines provided on the packaging. Discard any remaining medication. Ensure it remains inaccessible to children, pets, and other individuals.
Glimoso M 1mg/500mg Tablet use may result in lactic acidosis, a serious medical condition characterized by excessive blood lactic acid. Also termed Metformin-associated lactic acidosis (MALA), this uncommon adverse reaction poses a significant risk to individuals with kidney impairment, the elderly, or those who consume substantial alcohol. Symptoms can manifest as muscle aches or weakness, lightheadedness, fatigue, cold extremities, respiratory distress, nausea, vomiting, abdominal pain, or bradycardia. Should these symptoms arise, discontinue Glimoso M 1mg/500mg Tablet and seek immediate medical attention.
Glimoso M 1mg/500mg tablets contain glimepiride and metformin, acting together to manage type 2 diabetes mellitus in adults. This dual therapy enhances blood sugar control when combined with a healthy diet and exercise regimen. Glimepiride stimulates insulin secretion from the pancreas, thereby reducing blood glucose. Metformin reduces hepatic glucose production and increases insulin effectiveness. This formulation is unsuitable for type 1 diabetes.
Glimoso M 1mg/500mg tablets may cause common side effects including low blood sugar (hypoglycemia), taste changes, nausea, abdominal pain, diarrhea, and headache. Rare but serious adverse reactions such as lactic acidosis are also possible. Prolonged use might result in vitamin B12 deficiency.
Prolonged use of Glimoso M 1mg/500mg tablets can indeed lead to Vitamin B12 deficiency. This medication impedes Vitamin B12 absorption in the gastrointestinal tract. Untreated deficiency may result in anemia, neurological complications including paresthesia in the extremities, generalized weakness, urinary dysfunction, cognitive impairment, and gait instability. Preventive strategies proposed by some researchers include supplemental Vitamin B12 at least annually.
Indeed, Glimoso M 1mg/500mg Tablets may induce hypoglycemia (low blood glucose). Manifestations of low blood sugar can encompass nausea, headache, irritability, hunger pangs, sweating, vertigo, tachycardia, and feelings of anxiety or tremor. The likelihood increases with skipped or delayed meals, alcohol consumption, excessive physical activity, or concomitant use of other antidiabetic medications. Therefore, consistent blood glucose monitoring is crucial. Carrying a rapidly absorbable sugar source, such as glucose tablets, honey, or fruit juice, is advisable.
Consuming alcohol concurrently with Glimoso M 1mg/500mg Tablet is inadvisable due to the risk of reduced blood glucose, potentially causing hypoglycemia. Furthermore, this combination elevates the likelihood of lactic acidosis.
Glimoso M 1mg/500mg Table...
57
MRP 69
17% off